He is also coordinates the early phase trials in paediatric cancers. He co-founded the Metronomic Global Health Initiative in 2010. His research interests and topics include rare paediatric tumours, paediatric brain tumours and pharmacology (new anticancer agents, metronomic chemotherapy, drug repositioning, microtubule-targeting agents), and global oncology.